Nu-Med Plus (NUMD) Common Equity (2016 - 2021)
Nu-Med Plus' Common Equity history spans 10 years, with the latest figure at -$70017.0 for Q3 2021.
- Quarterly results put Common Equity at -$70017.0 for Q3 2021, down 131.59% from a year ago — trailing twelve months through Sep 2021 was -$70017.0 (down 131.59% YoY), and the annual figure for FY2020 was $467703.0, up 226.26%.
- Common Equity for Q3 2021 was -$70017.0 at Nu-Med Plus, down from -$1651.0 in the prior quarter.
- In the past five years, Common Equity ranged from a high of $467703.0 in Q4 2020 to a low of -$370432.0 in Q4 2019.
- The 5-year median for Common Equity is -$21024.0 (2018), against an average of -$9269.1.
- The sharpest move saw Common Equity soared 332.43% in 2018, then plummeted 1137.48% in 2019.
- Year by year, Common Equity stood at $68242.0 in 2017, then decreased by 28.89% to $48527.0 in 2018, then crashed by 863.35% to -$370432.0 in 2019, then surged by 226.26% to $467703.0 in 2020, then plummeted by 114.97% to -$70017.0 in 2021.
- According to Business Quant data, Common Equity over the past three periods came in at -$70017.0, -$1651.0, and $190955.0 for Q3 2021, Q2 2021, and Q1 2021 respectively.